Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) EPS (Weighted Average and Diluted) (2022 - 2025)

Incannex Healthcare's EPS (Weighted Average and Diluted) history spans 3 years, with the latest figure at -$0.02 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 93.94% to -$0.02 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.75, a 46.04% increase, with the full-year FY2025 number at -$1.35, down 17.39% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.02 in Q4 2025 for Incannex Healthcare, roughly flat from -$0.02 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for IXHL hit a ceiling of -$0.02 in Q3 2025 and a floor of -$0.51 in Q2 2025.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.26 across 3 years, with a median of -$0.31 in 2023.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 262.5% in 2024 and later surged 93.94% in 2025.
  • Tracing IXHL's EPS (Weighted Average and Diluted) over 3 years: stood at -$0.33 in 2023, then changed by 0.0% to -$0.33 in 2024, then surged by 93.94% to -$0.02 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for IXHL at -$0.02 in Q4 2025, -$0.02 in Q3 2025, and -$0.51 in Q2 2025.